DE69322654D1 - Verfahren zur herstellung von kristallen des wachstumshormones und die so erhaltenen kristalle - Google Patents

Verfahren zur herstellung von kristallen des wachstumshormones und die so erhaltenen kristalle

Info

Publication number
DE69322654D1
DE69322654D1 DE69322654T DE69322654T DE69322654D1 DE 69322654 D1 DE69322654 D1 DE 69322654D1 DE 69322654 T DE69322654 T DE 69322654T DE 69322654 T DE69322654 T DE 69322654T DE 69322654 D1 DE69322654 D1 DE 69322654D1
Authority
DE
Germany
Prior art keywords
crystals
pct
growth hormone
date
alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69322654T
Other languages
English (en)
Other versions
DE69322654T2 (de
Inventor
Ebba Florin-Robertsson
Elvy Hoekby
Ronny Lundin
Sirkka Thome
Gertrud Westin-Sjoedahl
Tomas Lundqvist
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Health AB
Original Assignee
Pharmacia and Upjohn AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from SE9203175A external-priority patent/SE9203175D0/xx
Application filed by Pharmacia and Upjohn AB filed Critical Pharmacia and Upjohn AB
Publication of DE69322654D1 publication Critical patent/DE69322654D1/de
Application granted granted Critical
Publication of DE69322654T2 publication Critical patent/DE69322654T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575Hormones
    • C07K14/61Growth hormone [GH], i.e. somatotropin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/06Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Endocrinology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Diabetes (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Steroid Compounds (AREA)
  • Crystals, And After-Treatments Of Crystals (AREA)
  • Medicinal Preparation (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DE69322654T 1992-10-28 1993-10-27 Verfahren zur herstellung von kristallen des wachstumshormones und die so erhaltenen kristalle Expired - Fee Related DE69322654T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE9203175A SE9203175D0 (sv) 1992-10-28 1992-10-28 Growth hormone
SE19939302278A SE9302278D0 (sv) 1992-10-28 1993-07-02 Growth hormone
PCT/SE1993/000885 WO1994010192A1 (en) 1992-10-28 1993-10-27 Process for manufacturing crystals of growth hormone and crystals thereby obtained

Publications (2)

Publication Number Publication Date
DE69322654D1 true DE69322654D1 (de) 1999-01-28
DE69322654T2 DE69322654T2 (de) 1999-06-17

Family

ID=26661557

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69322654T Expired - Fee Related DE69322654T2 (de) 1992-10-28 1993-10-27 Verfahren zur herstellung von kristallen des wachstumshormones und die so erhaltenen kristalle

Country Status (14)

Country Link
US (1) US5734026A (de)
EP (1) EP0669934B1 (de)
JP (1) JP3470135B2 (de)
AT (1) ATE174602T1 (de)
AU (1) AU679012B2 (de)
CA (1) CA2147482C (de)
DE (1) DE69322654T2 (de)
DK (1) DK0669934T3 (de)
ES (1) ES2126660T3 (de)
FI (1) FI110609B (de)
HK (1) HK1013299A1 (de)
NO (1) NO320171B1 (de)
SE (1) SE9302278D0 (de)
WO (1) WO1994010192A1 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9302278D0 (sv) * 1992-10-28 1993-07-02 Kabi Pharmacia Ab Growth hormone
US6500933B1 (en) 1997-09-05 2002-12-31 Altus Biologics Inc. Methods of preparing carbohydrate crosslinked glycoprotein crystals
DE69839563D1 (de) 1997-09-05 2008-07-10 Altus Pharmaceuticals Inc Kohlenhydrat-vernetzte glykoproteinkristalle
US6380357B2 (en) * 1997-12-16 2002-04-30 Eli Lilly And Company Glucagon-like peptide-1 crystals
US6541606B2 (en) * 1997-12-31 2003-04-01 Altus Biologics Inc. Stabilized protein crystals formulations containing them and methods of making them
KR20040085205A (ko) * 2002-02-20 2004-10-07 일라이 릴리 앤드 캄파니 Glp-1 분자의 투여 방법
SE0202719D0 (sv) * 2002-09-13 2002-09-13 Pharmacia Ab Process for mfg crystals of growth hormone
RU2357750C2 (ru) 2002-12-31 2009-06-10 Элтус Фармасьютикалз Инк. Кристаллы человеческого гормона роста и способы их получения
US20060286129A1 (en) * 2003-12-19 2006-12-21 Emisphere Technologies, Inc. Oral GLP-1 formulations
US7444197B2 (en) 2004-05-06 2008-10-28 Smp Logic Systems Llc Methods, systems, and software program for validation and monitoring of pharmaceutical manufacturing processes
US7799273B2 (en) 2004-05-06 2010-09-21 Smp Logic Systems Llc Manufacturing execution system for validation, quality and risk assessment and monitoring of pharmaceutical manufacturing processes
AU2006330833A1 (en) * 2005-12-23 2007-07-05 Altus Pharmaceuticals Inc. Compositions comprising polycation-complexed protein crystals and methods of treatment using them

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69125035T2 (de) * 1990-06-04 1997-07-10 Schering Corp Verfahren zur herstellung von interferon-alpha-2 kristallen
IL98484A0 (en) * 1990-06-15 1992-07-15 Schering Corp Crystalline interleukin-4
DK168790D0 (de) * 1990-07-13 1990-07-13 Novo Nordisk As
US5015627A (en) * 1990-07-20 1991-05-14 Smithkline Beecham Corporation Stabilized somatotropin for parenteral administration
SE9302278D0 (sv) * 1992-10-28 1993-07-02 Kabi Pharmacia Ab Growth hormone

Also Published As

Publication number Publication date
FI952021A (fi) 1995-04-27
ATE174602T1 (de) 1999-01-15
SE9302278D0 (sv) 1993-07-02
NO320171B1 (no) 2005-11-07
CA2147482C (en) 2003-09-23
DK0669934T3 (da) 1999-08-23
CA2147482A1 (en) 1994-05-11
NO951547D0 (no) 1995-04-24
HK1013299A1 (en) 1999-08-20
JP3470135B2 (ja) 2003-11-25
WO1994010192A1 (en) 1994-05-11
US5734026A (en) 1998-03-31
AU5401194A (en) 1994-05-24
DE69322654T2 (de) 1999-06-17
AU679012B2 (en) 1997-06-19
EP0669934B1 (de) 1998-12-16
JPH08505127A (ja) 1996-06-04
EP0669934A1 (de) 1995-09-06
FI952021A0 (fi) 1995-04-27
FI110609B (fi) 2003-02-28
ES2126660T3 (es) 1999-04-01
NO951547L (no) 1995-04-24

Similar Documents

Publication Publication Date Title
DE69322654D1 (de) Verfahren zur herstellung von kristallen des wachstumshormones und die so erhaltenen kristalle
KR860002958A (ko) 살균제의 제법
DE69621649T2 (de) Verfahren zur herstellung von cefdinir
DE69722027D1 (de) Kristalle von benzimidazolderivate und verfahren zu ihrer herstellung
DE69503604D1 (de) Stabilisierte orthokieselsäure enthaltende zubereitung sowie biologische zubereitung
GR3015558T3 (en) Chemically modified protein and production thereof.
DE69132318D1 (de) Verfahren zur herstellung von pyrimidinverbindungen
HUT36784A (en) Process for producing spasmolytic sulfanate derivatives and pharmaceutical compositions containing them as active agents
DE69104365T2 (de) Vaterit und verfahren zu dessen herstellung.
DE69126440T2 (de) Phosphorsäureester und ihre verwendung zur herstellung biokompatibler oberflächen
DE3675016D1 (de) Verfahren zur fluoreszenzverbesserung von ti:al2o3 laserkristallen durch kontrolle von kristallzuechtung-atmosphaeren.
ATE407127T1 (de) Verfahren zur herstellung von beraprost und dessen salzen
DE69614841D1 (de) Verfahren zur Herstellung von Galanthaminderivate durch asymmetrische Reduktion
ATE301659T1 (de) Verfahren zur herstellung von campothecinderivate
HUP0300227A2 (hu) Eljárás nagy tisztaságú 2-szubsztituált -1-(hidroxi-etilidén)-1,1-biszfoszfonsavak és sóik előállítására
DE3866148D1 (de) Chinolincarbonsaeure-derivate, diese enthaltende zusammensetzung, verfahren zu ihrer herstellung und ihre verwendung zur herstellung von medikamenten.
ATE188694T1 (de) Verfahren zur herstellung von benzopyranderivaten
DE69613101D1 (de) Verfahren zur herstellung von palatinitol
DE69404476D1 (de) Verfahren zur herstellung von rufloxacin und salze davon
DE3674122D1 (de) Verfahren zur herstellung optisch aktiver alpha-haloalkylarylketone.
DE69504188D1 (de) Verfahren zur herstellung von 5-amino-1,3-dioxanen
DE3669151D1 (de) Verfahren zur herstellung von 2-acyl-3,4-alkoxyanilinen.
ATE215071T1 (de) Verfahren zur herstellung von prostaglandin e1

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee